About
Organisation
General Assembly Members
FECC, IPEC-Americas, IPEC-China, IPEC Europe, PQG, SPPEA who have full and equal voting rights at formal meetings of members. Other individuals and organisations who have experience of and interest in pharmaceutical excipients may be considered for Associate membership. Associate members have no voting rights at formal meetings of members.
Board Members
| President | Dr Iain Moore, Croda representing IPEC Europe |
| Vice-President | Mr David Klug, Sanofi, representing IPEC-Americas |
| Treasurer | Mr Kevin McGlue, representing IPEC Europe |
| Board Member | Ms Bree Wang, Merck Group, representing IPEC China |
Operations
| Quality Manager | Mr Alain Becart, Consultant |
| Senior Adviser | Mr Adrian L. Bone, Expert |
| Administrative Coordinator | Ms Bosele Basunda (Chimene Bosele), EXCiPACT Secretariat |
Meet The Board
Iain Moore, President
Iain is Global Head of Quality Assurance Croda Europe Ltd, a manufacturer of speciality and performance chemicals based in the United Kingdom.
He has worked for Croda for 34 years, and for more than 25 years in various quality roles, including overseeing two UK regulatory inspections. He has contributed to the publication of European and US National Standards as well as many IPEC Guides. He was project leader for the development and delivery of the EXCiPACT Certification Scheme, and stood as its first President, and has latterly returned to the Board as the new President and Chairman of the Board succeeding Kevin McGlue who held the role since 2016 .
He is also chair of the EFFCI (European Federation for Cosmetic Ingredients) GMP Committee which oversees the EFfCI GMP Guide and standard for cosmetic Ingredients.
David Klug, Vice President
David is Industrial Regulatory Compliance Manager at Sanofi.
He is an Officer and Past Chair of IPEC-Americas. He also served on the Global Steering Committee and GMP Annex Team that developed the EXCiPACT Certification Standards for Pharmaceutical Excipient Suppliers and presently serves as Vice-President of the EXCiPACT Management Body. David is an industry representative on the NSF Joint Committee for Pharmaceutical Excipients that developed NSF/IPEC/ANSI 363 Good Manufacturing Practices (GMP) for Pharmaceutical Excipients. He has participated in the development of IPEC Guides published since 2001.
Formerly employed by Mallinckrodt, David holds an M.S. degree in Chemistry from the University of Missouri - Columbia.
Kevin McGlue, Treasurer
Kevin is a graduate in Chemistry and started his working career first as a Research & Development Chemist, then as a Process Chemist. He then spent six years as a Chemical Synthesis Plant Manager, and Formulations & Packing Manager managing a wide range of chemical synthesis and formulation activities for Schering A.G. He joined Colorcon in 1987, spending 11 years as Operations Manager and 8 years as Operations Director responsible for all Operational activities for Colorcon EMEA. In February 2006, he took up a new position as Director, Global Quality Assurance with overall responsibility for all QA and QC activities worldwide. In March 2022, Kevin retired from Colorcon.
Kevin is Treasurer of EXCiPACT asbl. He was EXCiPACT President from 2016-2019 and then continue to support the organisation in an expert quality. He is a former member and Vice-Chair of the Board of IPEC Europe and a past Chair of the IPEC Europe GMP committee. He was a member of the IPEC team responsible for the production of the 2006 Joint IPEC / PQG Excipient GMP guide, and led the task force for the 2017 revision. Kevin has published numerous articles on Excipient GMP and Change Management and is a regular speaker at seminars, conferences and training courses.
Bree Wang, Board Member
Bree is Regulatory Management Expert at Merck based in China, focus on API, excipient and food additive related regulatory topics.
After holding a Master degree in Chemistry from Nanjing University of Science & Technology in 2009, she started her career for regulatory topics, including oversea API registration, domestic excipient registration, regulatory advocacy, customer audit etc. and close cooperation with quality department for GMP/regulatory compliance topics. She is also a member of IPEC-China, serving in Quality sub-committee to deliver Excipient Good Manufacturing Practices principles to Chinese excipient industry.
Meet The Operations Team
Alain Becart, Quality Manager
Alain has a Doctorate in Industrial Pharmacy and a Masters degree in Analytical Chemistry and Quality Control. He started his career as Head of Quality Control in Pharmaceutical Manufacturing with the French offices of Ethypharm and Boehringer Ingelheim. In 1995, he joined Rhone Poulenc Rorer (a Sanofi legacy company) in their R&D – Analytical Sciences department with responsibility for clinical batches analysis and stability testing.
In 2005, he became responsible for Suppliers Quality Management worldwide within the Industrial Quality & Compliance corporate department Sanofi-Aventis, where he built a global system to manage the quality of third parties, including audits of manufacturers and distributors of pharmaceutical starting materials. He retired in October 2017 as Director Quality of Third Parties in SANOFI Global Quality based in Paris.
Since 2010, Alain has been President of the Pharmaceutical Starting Material Forum within the Quality Group of the LEEM - the professional organisation of pharmaceutical companies operating in France. In January, 2017, he became the Quality Manager of EXCiPACT asbl with responsibility for the approval of their Registered Certification Bodies and Registered Auditors, and for ensuring compliance of EXCiPACT certification actions with regards to ISO 19011 and ISO 17021 standards.
Adrian L. Bone, Senior Advisor
Adrian graduated in Pharmacy from the University of London after which he had a career of more than 35 years in the pharmaceutical industry both in the UK and internationally. He held senior positions in several functions, primarily in quality assurance overseeing manufacturing and supply operations for medicines. Adrian was the Chair of IPEC Europe for two terms. He also contributed to the certification project that became EXCiPACT. Currently, Adrian works in an advisory capacity to IPEC Europe, the IPEC Federation and EXCiPACT, assisting these associations in their goals to exchange good practices and to develop harmonised standards for pharmaceutical excipients.
Membership
Under the Articles of the Association, full Membership of EXCiPACT asbl can only be granted to trade associations or similar organisations that represent groups of organisations who have an interest in manufacturing, distributing or using pharmaceutical excipients, and Competent Authorities responsible for upholding safety and quality standards for excipients. All those interested in becoming a member should contact the EXCiPACT Secretariat at info@excipact.org or complete our contact form in the first instance.
Quality Policy
The EXCiPACT Association is committed to achieving excellence and providing our entire community supply chain with a set of high-quality services designed, produced, and maintained to meet or exceed their expectations. You can read about our Quality Policy here.
Corporate Governance
EXCiPACT asbl is a Belgian not-for-profit association following the rules set by the Articles of Association. To support the values and related perceptions of our industry, it is essential that EXCiPACT asbl not only complies with statutory provisions and legal requirements regarding the essential features of the association (e.g. conduct of non-profit activities, fulfilment of the financial / taxes obligations), but also operates to the highest level of ethical standards. Our Governance and Compliance Policy reflects this.
Useful Links
The links on this page connect to sites which EXCiPACT believes may be useful to its website readers. EXCiPACT is not responsible for the content of any of the external sites listed.
Regulatory Agencies
Industry Associations